@article{article, title  = {{Effect of nonmyeloablative hematopoietic stem cell transplantation vs continued disease-modifying therapy on disease progression in patients with relapsing-remitting multiple sclerosis: a randomized clinical trial}},

 publisher = {{American Medical Association}},

 url = {{https://eprints.whiterose.ac.uk/id/eprint/141525 https://doi.org/10.1001/jama.2018.18743 }},

 year = {{2019}},

 month = {{1}},

 author = {{Burt RK and Balabanov R and Burman J and Sharrack B and Snowden JA and Oliveira MC and Fagius J and Rose J and Nelson F and Barreira AA and Carlson K et al}},

 doi = {{10.1001/jama.2018.18743}},

 volume = {{321}},

 journal = {{Journal of the American Medical Association}},

 issue = {{2}},

 pages = {{165-174}},

 note = {{Accessed on 2025/11/15}}}